People with Parkinson's disease invited to participate in medication study

The department of neurology at University of Iowa Hospitals and Clinics
is beginning the study of a new medication for Parkinson's disease. This new
agent is intended to slow down or stop the progression of Parkinson's disease
by preventing the death of brain cells that occurs in this condition.

The study of this drug is being conducted in cooperation with the Parkinson's
Study Group, a group of academic medical centers in North America devoted
to the development of new, effective therapies for Parkinson's disease.

Patients who have been diagnosed with Parkinson's disease for less than
five years and who are not taking any Parkinson's medications may be eligible
to participate in the program.

The study is for 24 months with 12 clinical visits. Two all-expense paid
trips to the Institute for Neurodegenerative Disorders in New Haven, Conn.,
will also be required.

Inquires can be directed to Judith Dobson at (319) 356-8958.

University of Iowa Health Care describes the partnership between
the UI Roy J. and Lucille A. Carver College of Medicine and UI Hospitals and
Clinics and the patient care, medical education and research programs and
services they provide. Visit UI Health Care online at www.uihealthcare.com.